Andrea (Flynn) Franson, MD, MS

Andrea Franson, MD, MS
Clinical Associate Professor of Pediatrics
Fellowship Director of Pediatric Hematology/Oncology
Medical School
Department of Pediatrics
D4202 MPB
Ann Arbor, MI 48109-5718
Available to mentor
Andrea (Flynn) Franson, MD, MS
Andrea Franson, MD, MS
Clinical Associate Professor
  • About
  • Links
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile

  • About

    Dr. Andrea (Flynn) Franson is a Pediatric Oncologist in the Department of Pediatrics at the University of Michigan. She received her bachelor’s degree from Rensselaer Polytechnic Institute in Troy, New York and her medical degree from the University of Michigan Medical School. She completed her residency in Pediatrics and fellowship in Pediatric Hematology/Oncology at the Children’s Hospital of Philadelphia (CHOP). During fellowship, she earned a master’s degree in Pharmacology from Thomas Jefferson University. She joined as faculty at the University of Michigan in 2019.

    Links

    • twitter

    Qualifications

    • Fellowship
      Children's Hospital of Philadelphia, Pediatric Hematology and Oncology, Philadelphia, United States
      2014 - 2017
    • Clinical Pharmacology Fellow
      Thomas Jefferson University, Pharmacology and Experimental Therapeutics, Philadelphia, United States
      2015 - 2017
    • Residency
      Children's Hospital of Philadelphia, Pediatrics, Philadelphia, United States
      2012 - 2014
    • Internship
      Children's Hospital of Philadelphia, Pediatrics, Philadelphia, United States
      2011 - 2012
    • MS, Pharmacology
      Thomas Jefferson University, 130 S. Ninth Street, Suite 100, Philadelphia, PA, 19107, United States
      2015 - 2017
    • MD
      University of Michigan, Ann Arbor, MI, United States
      2007 - 2011
    • BS
      Rensselaer Polytechnic Institute, Troy, NY, United States
      2003 - 2007

    Center Memberships

    • Center Member
      Rogel Cancer Center

    Research Overview

    Broadly, Dr. Franson's research interests are in the clinical translation of promising therapeutic approaches from the lab into pediatric patients with high-risk brain tumors. She collaborates with several basic science laboratories on campus to move successful compounds or immunotherapies into pediatric and AYA focused clinical trials, with an interest in novel clinical trial designs and the use of PK/PD-informed dosing.

    Recent Publications

    See All Publications
    • Proceeding / Abstract / Poster
      Germling findings of cancer risk predisposition syndromes in pediatric and young adult patients with high grade glioma
      Grotewold N, Kandiraju S, Kumar-Sinha C, Robertson DR, Wu Y-M, Vo J, Chinnaiyan A, Mody R, Upadhyaya S, Jacobs MF, Franson A. 2026 May 7;
    • Journal Article
      Multi-Institutional Annotated Multiparametric MRI Dataset of Pediatric High-Grade Gliomas.
      Fathi Kazerooni A, Jiang Z, Gandhi D, Khalili N, Liu X, Tu W, Ware JB, Familiar AM, Vunnava B, Zapaishchykova A, McAllister AS, Sanchez-Montano M, Sheth N, Nandolia KK, Lai HA, Pavaine J, Prabhu SP, Haldar D, Varshochi S, Bagheri S, Anderson H, Haldar S, Khalili N, Gottipati A, Shaikh IS, Castellino E, Mangoli A, Gohil H, Maleki N, Low J, Hummel T, Packer RJ, Franson A, Storm PB, Bakas S, Calabrese E, Aboian M, de Blank P, Kann BH, Rood B, Resnick AC, Nabavizadeh A, Vossough A, Linguraru MG. Radiol Artif Intell, 2026 Apr 29; e250902 DOI:10.1148/ryai.250902
      PMID: 42053414
    • Journal Article
      Clinical stability after tovorafenib treatment in patients with relapsed/refractory pediatric low-grade glioma: Updated results from the phase 2 FIREFLY-1 trial
      Kline C, Landi D, Khuong-Quang D-A, Nysom K, Kilburn LB, Waanders AJ, Perreault S, Mueller S, McCowage G, Driever PH, Leary SES, Ziegler DS, Kang HJ, Witt O, Baxter PA, Bailey S, Chi SN, Han JW, Abdelbaki MS, Hassall TE, Franson AT, Hargrave D, Toledano H, Oren MY, Jabado N, Gottardo NG, Gerber NU, Renzi S, Segal D, Tan EEK, Oren L, Whipple NS, Hansford JR, Pehlivan K, Zhang J, Manley P, Ott L, Barry E, Maher JC, van der Lugt J. Neuro-Oncology Pediatrics, 2026 Apr 24; DOI:10.1093/neuped/wuag022
    • Journal Article
      Clinical safety and efficacy of bevacizumab in combination with mitogen-activated protein kinase kinase inhibitor therapy for glioma: a retrospective analysis
      Kotch C, Avery RA, Franson AT, Hargrave D, Brossier NM, Bornhorst M, Rangnath S, Nevel KS, Robison NJ, Liu GT, Fisher MJ, de Blank P. Neuro-Oncology Pediatrics, 2026 Feb 28; 2 (1): DOI:10.1093/neuped/wuag011
    • Journal Article
      ZFTA-RELA ependymomas make itaconate to epigenetically drive fusion expression.
      Natarajan SK, Lum J, Skeans JH, Nenwani M, Eyunni S, Mota M, Bayliss JM, Deogharkar A, Hamanishi ET, Pun M, Sweha SR, Hoffman S, Young E, Zhang Q, Mehta R, Animasahun O, Narayanan P, Sunil S, Parolia A, Sajjakulnukit P, Panwalkar P, Doherty R, Clausen M, Dang D, Hawes D, Yang F, Santi M, Judkins AR, Wilson Y, Vigil T, Franson A, Mortensen RM, Ozawa T, Griesinger A, Holland EC, Foreman NK, Michealraj KA, Agnihotri S, Taylor M, Gilbertson RJ, Koschmann C, Chinnaiyan AM, Lyssiotis CA, Nagrath D, Venneti S. Nature, 2026 Feb 4; DOI:10.1038/s41586-025-10005-1
      PMID: 41639460
    • Journal Article
      AI-powered segmentation and prognosis with missing MRI in pediatric brain tumors.
      Chrysochoou D, Gandhi DB, Adib S, Familiar AM, Vunnava B, Varshochi S, Khalili N, Khalili N, Ware JB, Tu W, Jain P, Anderson H, Haldar S, Storm PB, Franson A, Prados M, Kline C, Mueller S, Resnick A, Vossough A, Davatzikos C, Nabavizadeh A, Kazerooni AF. NPJ Precis Oncol, 2026 Jan 13; DOI:10.1038/s41698-025-01269-x
      PMID: 41530498
    • Journal Article
      Pediatric Oncology Patients With Germline Pathogenic Variants in Adult-Onset Cancer Predisposition Genes
      Jacobs MF, Austin S, Murad A, Koeppe E, Kumar-Sinha C, Robinson DR, Wu Y-M, Vo JN, Koschmann C, Robertson P, Franson A, Leung D, Chinnaiyan AM, Mody RJ. JCO Precision Oncology, 2025 Dec 4; 9: DOI:10.1200/PO-24-00749
    • Journal Article
      CNSC-68. LEVETIRACETAM THERAPEUTICALLY TARGETS GABAERGIC SYNAPSES IN DIFFUSE MIDLINE GLIOMA
      Barron T, Yalçin B, Su M, Mochizuki A, Drexler R, Cantor E, Byun YG, Gavish A, Shamardani K, Xu H, Ni L, Soni N, Tlais D, Franson A, Lyons S, Mehta V, Kim YS, Taylor KR, Quezada MA, Keough MB, Jahan SM, Geraghty AC, Mancusi R, Vo LT, Casteñeda EH, Woo PJ, Ricklefs FL, Schüller U, Petritsch CK, Vogel H, Fisher PG, Campen CJ, Partap S, Kaila K, Koschmann C, Monje M. Neuro-Oncology, 2025 Nov 12; 27 (Supplement_5): v69 - v69. DOI:10.1093/neuonc/noaf201.0275
      PMID: PMC12600757

    Featured News & Stories

    parents posing in selfie up close with kid in front of them
    Health Lab

    4-year-old pediatric brain cancer patient wins over his care team with cheerful personality

    Pediatric cancer patient at Michigan Medicine was diagnosed with ATRT and underwent chemotherapy and radiation. Four years later, he’s doing well.
    cells spikey on pink background purple spikes
    Health Lab

    New clinical trials for pediatric brain tumors

    Brain and spinal cord tumors account for one in four childhood cancers. Although 75% of children survive for at least five years after being diagnosed, many patients have recurrent tumors that cannot be cured. Andrea Franson discusses current therapies for pediatric brain tumors, how viruses can be used to target tumor cells and the new phase 1 trial that started in May 2025.
    Department News

    Department of Pediatrics Faculty Promotions

    U-M faculty across pediatrics, cardiology, psychology & more were promoted in 2025, recognizing excellence in clinical and academic leadership.
    Department News

    New clinical trials for pediatric brain tumors

    Pediatric brain tumors are tough to treat—new trials use viruses to boost immunity and target recurring cancer cells. Hope is rising.